Globally, nearly 900,000 new cases per year of lung cancer are diagnosed in men and 330,000 in women, according to figures from theNational Cancer Institute. It is the most common and deadly form of cancer in the world. In order to better understand the needs of patients and the difficulties they encounter on a daily basis, the German pharmaceutical group Boehringer Ingelheim and the Global Lung Cancer coalition have launched a major international survey. Patients and their relatives are now invited to answer them on the site. wearelistening.info.
Self-esteem, finances, treatments, relationship with healthcare professionals … every aspect of the patient’s life is scrutinized. “If you, one of your loved ones or a person you are supporting has lung cancer, we are at your disposal to find out what challenges you have to face in your daily life”, we read on the site. At the end of the questionnaire, references are made to the main websites of institutional players such as e-cancer.fr and ligue-cancer.net to try to answer certain questions.
The results will be communicated to everyone involved in the management of this type of cancer. “The information collected will thus make it possible to propose new management strategies and tools that will meet the needs and expectations of patients”, hope the initiators of the project. An objective that is part of the Cancer plan 2014-2019.